BNP Paribas’s CME Group CME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.19M Buy
14,460
+608
+4% +$168K 0.09% 116
2026
Q1
$4.1M Buy
13,852
+2,152
+18% +$639K 0.13% 103
2025
Q4
$3.2M Buy
11,700
+11,181
+2,154% +$3.04M 0.09% 120
2025
Q3
$141K Hold
519
﹤0.01% 231
2025
Q2
$144K Buy
519
+457
+737% +$124K ﹤0.01% 235
2025
Q1
$16.4K Buy
+62
New +$15.3K ﹤0.01% 297

Other funds holding CME

BNP Paribas's CME Position: Q2 2026 in Review

BNP Paribas increased its CME Group (CME) stake by 4.4% in Q2 2026, buying an estimated $168K and bringing the position to 14,460 shares worth $3.19M. The position accounts for 0.09% of the portfolio, ranked #116.

BNP Paribas first reported a position in CME in Q1 2025 and has held it in 6 quarters since. The position peaked at $4.1M in Q1 2026. 1,703 funds tracked by Wall St. Rank hold CME as of Q2 2026.

  • BNP Paribas held 14,460 shares of CME Group worth $3.19M as of Q2 2026.
  • BNP Paribas bought 608 CME Group shares in Q2 2026, an estimated $168K.
  • CME Group made up 0.09% of BNP Paribas's portfolio in Q2 2026, its #116 holding.
  • BNP Paribas first reported a position in CME Group in Q1 2025 and has held it in 6 quarters since.
  • BNP Paribas's CME Group position peaked at $4.1M in Q1 2026.
  • 1,703 funds tracked by Wall St. Rank held CME Group as of Q2 2026.

Based on BNP Paribas's 13F filing for Q2 2026, filed 13 Aug 2026.